characterized the role of G9a/GLP complex as a promising epigenetic regulator in MM; the authors showed that G9a/GLP targeting in MM cells induce autophagy-associated apoptosis and makes MM cells more susceptible to PI-based therapy by blocking mTOR signaling and lowering c-MYC levels. This evidence concerns the gene MTOR and Miyoshi myopathy.